UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically

Arteriosclerosis, thrombosis, and vascular biology, 2016-12, Vol.36 (12), p.2439

2016

Volltextzugriff (PDF)

Clinical and biochemical features of different molecular etiologies of familial chylomicronemia

Journal of clinical lipidology, 2018-07, Vol.12 (4), p.920-927.e4

2018

Volltextzugriff (PDF)

Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias

BMC medical genomics, 2020-02, Vol.13 (1), p.23-23, Article 23

2020

Volltextzugriff (PDF)

Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia

Circulation. Genomic and precision medicine, 2020-10, Vol.13 (5), p.515-523

2020

Volltextzugriff (PDF)

Genetic determinants of statin intolerance

Lipids in health and disease, 2007-03, Vol.6 (1), p.7-7, Article 7

2007

Volltextzugriff (PDF)

Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-I

Journal of lipid research, 2009-06, Vol.50 (6), p.1223-1228

2009

Volltextzugriff (PDF)

Targeted exonic sequencing of GWAS loci in the high extremes of the plasma lipids distribution

Atherosclerosis, 2016-07, Vol.250, p.63-68

2016

Volltextzugriff (PDF)

Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia

CJC open (Online), 2019-05, Vol.1 (3), p.115-118

2019

Volltextzugriff (PDF)

Genetic Confirmation Rate in Clinically Suspected Maturity-Onset Diabetes of the Young

Canadian journal of diabetes, 2016-12, Vol.40 (6), p.555-560

2016

Volltextzugriff (PDF)

Targeted next-generation sequencing in monogenic dyslipidemias

Current opinion in lipidology, 2015-04, Vol.26 (2), p.103-113

2015

Volltextzugriff (PDF)

Genetic Determinants of Myocardial Infarction Risk in Familial Hypercholesterolemia

CJC open (Online), 2019-09, Vol.1 (5), p.225-230

2019

Volltextzugriff (PDF)

NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe

Lipids in health and disease, 2005-08, Vol.4 (1), p.16-16, Article 16

2005

Volltextzugriff (PDF)

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia

Nature genetics, 2010-08, Vol.42 (8), p.684-687

2010

Volltextzugriff (PDF)

Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia

Journal of lipid research, 2005-02, Vol.46 (2), p.366-372

2005

Volltextzugriff (PDF)

Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk Score

CJC open (Online), 2019-03, Vol.1 (2), p.69-75

2019

Volltextzugriff (PDF)

Common low-density lipoprotein receptor p.G116S variant has a large effect on plasma low-density lipoprotein cholesterol in circumpolar inuit populations

Circulation. Cardiovascular genetics, 2015-02, Vol.8 (1), p.100

2015

Volltextzugriff (PDF)

Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample

Cardiovascular diabetology, 2008-03, Vol.7 (1), p.5-5, Article 5

2008

Volltextzugriff (PDF)

The Effect of Infrequent Low-Dose Rosuvastatin on the Lipid Profile

Canadian journal of cardiology, 2014-11, Vol.30 (11), p.1392-1395

2014

Volltextzugriff (PDF)

Western Database of Lipid Variants (WDLV): A Catalogue of Genetic Variants in Monogenic Dyslipidemias

Canadian journal of cardiology, 2013-08, Vol.29 (8), p.934-939

2013

Volltextzugriff (PDF)

Clinical Equivalence of Proprietary and Generic Atorvastatin in Lipid Clinic Patients

Canadian journal of cardiology, 2013-04, Vol.29 (4), p.418-422

2013

Volltextzugriff (PDF)

Efficacy and Plasma Drug Concentrations With Nondaily Dosing of Rosuvastatin

Canadian journal of cardiology, 2013-08, Vol.29 (8), p.915-919

2013

Volltextzugriff (PDF)

Defective KIM-1 phagocytosis does not predispose to acute graft dysfunction after kidney transplantation in humans

Kidney international, 2022-08, Vol.102 (2), p.435-439

2022

Volltextzugriff (PDF)

Incremental Lowering of Low-Density Lipoprotein Cholesterol With Ezetimibe 20 mg vs 10 mg Daily in Patients Receiving Concomitant Statin Therapy

Canadian journal of cardiology, 2013-11, Vol.29 (11), p.1395-1399

2013

Volltextzugriff (PDF)

APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians

Journal of lipid research, 2010-04, Vol.51 (4), p.843-848

2010

Volltextzugriff (PDF)

G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studies

Arteriosclerosis, thrombosis, and vascular biology, 2015-01, Vol.35 (1), p.213

2015

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(85)
Bücher
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically

Clinical and biochemical features of different molecular etiologies of familial chylomicronemia

Six years' experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias

Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia

Genetic determinants of statin intolerance

Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-I

Targeted exonic sequencing of GWAS loci in the high extremes of the plasma lipids distribution

Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia

Genetic Confirmation Rate in Clinically Suspected Maturity-Onset Diabetes of the Young

Targeted next-generation sequencing in monogenic dyslipidemias

Genetic Determinants of Myocardial Infarction Risk in Familial Hypercholesterolemia

NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe

Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia

Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia

Clinical Utility and Practical Considerations of a Coronary Artery Disease Genetic Risk Score

Common low-density lipoprotein receptor p.G116S variant has a large effect on plasma low-density lipoprotein cholesterol in circumpolar inuit populations

Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample

The Effect of Infrequent Low-Dose Rosuvastatin on the Lipid Profile

Western Database of Lipid Variants (WDLV): A Catalogue of Genetic Variants in Monogenic Dyslipidemias

Clinical Equivalence of Proprietary and Generic Atorvastatin in Lipid Clinic Patients

Efficacy and Plasma Drug Concentrations With Nondaily Dosing of Rosuvastatin

Defective KIM-1 phagocytosis does not predispose to acute graft dysfunction after kidney transplantation in humans

Incremental Lowering of Low-Density Lipoprotein Cholesterol With Ezetimibe 20 mg vs 10 mg Daily in Patients Receiving Concomitant Statin Therapy

APOC1 T45S polymorphism is associated with reduced obesity indices and lower plasma concentrations of leptin and apolipoprotein C-I in aboriginal Canadians

G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studies

Suchergebnisse filtern